ArticleMolecular therapy. Nucleic acids2018

Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2

Xiaolin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.